The NSW authorities has launched a brand new $20 million fund aimed toward serving to startups and progressive corporations flip emerging applied sciences into industrial merchandise. It additionally introduced new grants for a number of bioscience startups.
Related Article Block Placeholder
Article ID: 332200
Innovation, Science and Technology Minister Anoulack Chanthivong revealed the Emerging Technologies Commercialisation Fund at an occasion at Sydney’s local weather tech hub, Greenhouse, final week.
The fund was first outlined in the 2025–26 NSW budget and kinds a part of the federal government’s Innovation Blueprint, its broader plan for supporting innovation and analysis commercialisation in NSW. The first funding spherical has a $7 million pool.
Chanthivong said this system is aimed toward a standard problem confronted by emerging know-how corporations attempting to deliver improvements to market.
“It targets the well-known ‘gap’ in the innovation pipeline: the stage where promising technologies have early evidence but still need funding and support to mature into investable, scalable solutions,” he stated.
“The new fund does this through repayable grants that help de-risk development and accelerate commercialisation outcomes.”
The program incorporates parts of the state’s Biosciences Fund and Physical Sciences Fund, whereas increasing assist to applied sciences that might strengthen native manufacturing functionality.
Alongside the announcement, the federal government additionally revealed new recipients of the $4.75 million Biosciences Fund, a commercialisation program supporting biotechnology and life sciences startups.
Related Article Block Placeholder
Article ID: 332259
The newest spherical included All G, which is creating toddler diet designed to extra carefully replicate the composition of human breast milk. HydGene Renewables additionally acquired funding for a biocatalyst know-how that converts waste biomass into inexperienced hydrogen used to provide industrial chemical substances reminiscent of ammonia and methanol.
Funding additionally went to Number 8 Bio, which is creating a methane inhibitor designed to cut back emissions from cattle and sheep. The startup acquired $11 million in a Series A round back in November.
Swan Genomics acquired assist for a simplified DNA sequencing platform aimed toward making the know-how cheaper and extra accessible for hospitals and diagnostic laboratories.